…
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
P3 Health Partners operates a national network providing outsourced physical therapy, occupational therapy, sports medicine and athletic training services to health systems, hospitals, clinics and employers. Long-term growth may be supported by an aging population, rising demand for outpatient rehabilitation and a shift toward value-based care, and the company appears positioned to benefit from consolidation opportunities in a fragmented market. Investors may find exposure to recurring service contracts and potential scale benefits attractive.
Principal risks include reimbursement and regulatory pressure, contract concentration, competition for clinicians and execution risk tied to growth and acquisition integration.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -321.06M | -305.99M | -183.73M | -31411.54M | - |
| Minority interest | 175.14M | 174.53M | 523.31M | 1291.43M | - |
| Net income | -147.95M | -135.85M | -57.77M | -10.08M | - |
| Selling general administrative | 106.31M | 112.60M | 122.36M | 53390.34M | - |
| Selling and marketing expenses | 0.92M | 1.33M | 3.23M | 1502.63M | - |
| Gross profit | -144.32M | 1500.45M | 1266.38M | 491063.53M | - |
| Reconciled depreciation | 84.16M | 86.06M | 87.04M | 87.29M | - |
| Ebit | -266.03M | -283.82M | -167.75M | -155.89M | -187.95M |
| Ebitda | -181.86M | -197.76M | -81.07M | -31411.54M | - |
| Depreciation and amortization | 84.16M | 86.06M | 86.67M | 0.09M | - |
| Operating income | -270.30M | -312.60M | -167.93M | -31411.54M | - |
| Other operating expenses | 1729.38M | 1813.06M | 1434.31M | 519651.20M | 37.84M |
| Interest expense | 55.03M | 22.17M | 15.98M | 2533.18M | - |
| Tax provision | 2.02M | 4.39M | 2.79M | 1.86M | - |
| Net interest income | -55.03M | -22.17M | -14.93M | -11.40M | - |
| Income tax expense | 2.02M | 4.39M | 2.69M | -31401.46M | - |
| Total revenue | 1459.08M | 1500.45M | 1266.38M | 491063.53M | - |
| Total operating expenses | 125.98M | 1813.06M | 1434.31M | 519651.20M | - |
| Cost of revenue | 1603.40M | 1559.37M | 1234.74M | - | - |
| Total other income expense net | -50.76M | 6.61M | -15.80M | -1302.30M | - |
| Net income from continuing ops | -323.09M | -310.38M | -649.65M | -1561.56M | - |
| Net income applicable to common shares | - | - | - | -270.13M | -10.08M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 656.64M | 783.42M | 860.97M | 2364.11M | 2364.11M |
| Intangible assets | 492.42M | 574.35M | 666.73M | 835.84M | 835.84M |
| Other current assets | 15.61M | 20.11M | 3.61M | 57566.36M | 7.32M |
| Total liab | 796.88M | 633.89M | 427.31M | 299.94M | 299.94M |
| Total stockholder equity | -155.23M | 75.94M | 142.13M | 273.55M | 273.55M |
| Other current liab | 418.68M | 367.41M | 62.31M | 177.42M | 177.42M |
| Common stock | - | 0.04M | 0.03M | 0.02M | 0.02M |
| Capital stock | 0.00M | 0.04M | 0.03M | 0.02M | 0.02M |
| Retained earnings | -651.14M | -503.19M | -367.34M | -39.42M | -39.42M |
| Other liab | - | - | - | - | 14.87M |
| Good will | - | - | - | 1309.75M | 1309.75M |
| Other assets | - | - | - | 4.29M | 3.59M |
| Cash | 25.01M | 38.82M | 40.93M | 140.48M | 140.48M |
| Total current liabilities | 545.26M | 496.42M | 299.37M | 198.77M | 198.77M |
| Current deferred revenue | - | - | 12.70M | - | - |
| Net debt | 259.87M | 127.35M | 83.71M | -50.56M | -50.56M |
| Short term debt | 45.04M | 65.00M | 2.70M | 3.62M | 3.62M |
| Short long term debt | 45.04M | 65.00M | - | - | 3.62M |
| Short long term debt total | 284.88M | 166.16M | 124.64M | 89.92M | 89.92M |
| Other stockholder equity | 495.91M | 579.09M | 509.44M | 312.95M | - |
| Property plant equipment | - | - | - | 20.54M | 15.07M |
| Total current assets | 133.08M | 184.14M | 166.02M | 199.86M | 199.86M |
| Net tangible assets | - | - | - | - | -1872.04M |
| Net receivables | 92.46M | 125.21M | 121.47M | 52.07M | 52.07M |
| Long term debt | 228.37M | 89.82M | 108.32M | 94.42M | 80.00M |
| Inventory | - | - | - | -57559.04M | - |
| Accounts payable | 81.55M | 64.01M | 221.66M | 17.73M | 17.73M |
| Accumulated other comprehensive income | - | - | 0.00M | - | - |
| Non currrent assets other | 27.76M | 19.20M | 4.23M | 3.59M | 3.59M |
| Non current assets total | 523.56M | 599.28M | 694.95M | 2164.25M | 2164.25M |
| Capital lease obligations | 11.47M | 11.34M | 13.62M | 11.52M | 6.30M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | 14.53M | -1.99M | -7.73M | - |
| Change to liabilities | - | - | - | 0.00M | 41.96M |
| Total cashflows from investing activities | 0.13M | 14.53M | -1.83M | - | -56.06M |
| Net borrowings | 73.00M | 58.95M | 14.10M | - | 28.53M |
| Total cash from financing activities | 72.81M | 98.77M | 100.33M | 34760.06M | 223.47M |
| Change to operating activities | - | - | - | - | 33.82M |
| Net income | -323.09M | -310.38M | -186.43M | -31411.54M | -156.48M |
| Change in cash | -18.30M | 3.17M | 22.48M | 6998.10M | 100.93M |
| Begin period cash flow | 44.10M | 40.93M | 18.46M | 32904.85M | 39.90M |
| End period cash flow | 25.81M | 44.10M | 40.93M | 39902.95M | 39.90M |
| Total cash from operating activities | -91.24M | -110.13M | -76.03M | -24595.81M | -66.47M |
| Issuance of capital stock | - | - | 87.24M | 0.00M | - |
| Depreciation | 84.16M | 86.06M | 86.67M | 795.17M | 8.72M |
| Other cashflows from investing activities | 0.13M | 14.53M | - | - | 0.21M |
| Change to account receivables | 28.68M | -3.76M | -41.99M | 139.21M | 0.45M |
| Sale purchase of stock | - | - | -0.02M | - | - |
| Other cashflows from financing activities | -0.19M | 39.82M | -0.36M | 34760.06M | -0.38M |
| Change to netincome | - | - | - | 22.00M | 51.56M |
| Capital expenditures | 0.08M | 0.00M | 1.83M | 2926.62M | 3.41M |
| Change in working capital | 81.91M | 87.98M | 30.30M | 8241.88M | - |
| Stock based compensation | 5.58M | 5.75M | 5.98M | 447.48M | - |
| Other non cash items | 57.33M | 21.55M | -12.55M | 5573.08M | - |
| Free cash flow | -91.24M | -110.13M | -77.86M | -27522.44M | - |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PIII P3 Health Partners Inc |
0.15 3.75% |
4.15 | - | - | 1.08 | 0.62 | 0.20 | -1.86 |
| HCA HCA Healthcare, Inc. |
9.74 1.97% |
504.73 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
10.62 3.75% |
293.95 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.27 1.86% |
14.79 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
0.29 5.59% |
5.57 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.
| Name | Title | Year Born |
|---|---|---|
| Dr. Sherif Abdou F.A.C.E.P., FACP, M.D. | Co-Founder, CEO & Director | 1960 |
| Dr. Amir Bacchus M.B.A., M.D. | Co-Founder, Chief Medical Officer & Director | 1965 |
| Mr. Atul Kavthekar | Chief Financial Officer | NA |
| Ms. Lorie Glisson CPA | Exec. Vice Chairwoman, COO & Florida Market Pres | NA |
| Ms. Erin Darakjian | Sr. VP & Chief Accounting Officer | NA |
| Mr. Devery Goodey | Sr. VP of Technology | NA |
| Ms. Karen Blomquist | VP of Investor Relations | NA |
| Ms. Jessica Puathasnanon | Chief Legal Officer, Gen. Counsel & Sec. | NA |
| Ms. Cheyenne Ross | VP of Compliance | NA |
| Ms. Kassi Belz APR | Exec. VP of Communications, Culture & Engagement | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.